Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
766
archived clinical trials in
Cosmetic

Mirvaso in Use Study
MIRVASO® In Use Study: Managing Rosacea Through Assessment and Control of Its Erythema (The MIRACLE Study)
Status: Enrolling
Updated:  11/21/2017
Florida Academic Dermatology Center
mi
from
Miami, FL
Mirvaso in Use Study
MIRVASO® In Use Study: Managing Rosacea Through Assessment and Control of Its Erythema (The MIRACLE Study)
Status: Enrolling
Updated: 11/21/2017
Florida Academic Dermatology Center
mi
from
Miami, FL
Click here to add this to my saved trials
Mirvaso in Use Study
MIRVASO® In Use Study: Managing Rosacea Through Assessment and Control of Its Erythema (The MIRACLE Study)
Status: Enrolling
Updated:  11/21/2017
Research Institute of the Southeast
mi
from
West Palm Beach, FL
Mirvaso in Use Study
MIRVASO® In Use Study: Managing Rosacea Through Assessment and Control of Its Erythema (The MIRACLE Study)
Status: Enrolling
Updated: 11/21/2017
Research Institute of the Southeast
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Mirvaso in Use Study
MIRVASO® In Use Study: Managing Rosacea Through Assessment and Control of Its Erythema (The MIRACLE Study)
Status: Enrolling
Updated:  11/21/2017
Grekin Skin Institute
mi
from
Warren, MI
Mirvaso in Use Study
MIRVASO® In Use Study: Managing Rosacea Through Assessment and Control of Its Erythema (The MIRACLE Study)
Status: Enrolling
Updated: 11/21/2017
Grekin Skin Institute
mi
from
Warren, MI
Click here to add this to my saved trials
Mirvaso in Use Study
MIRVASO® In Use Study: Managing Rosacea Through Assessment and Control of Its Erythema (The MIRACLE Study)
Status: Enrolling
Updated:  11/21/2017
Advanced Skin Research Center
mi
from
Omaha, NE
Mirvaso in Use Study
MIRVASO® In Use Study: Managing Rosacea Through Assessment and Control of Its Erythema (The MIRACLE Study)
Status: Enrolling
Updated: 11/21/2017
Advanced Skin Research Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Mirvaso in Use Study
MIRVASO® In Use Study: Managing Rosacea Through Assessment and Control of Its Erythema (The MIRACLE Study)
Status: Enrolling
Updated:  11/21/2017
Manhattan Dermatology and Cosmetic Surgery
mi
from
New York, NY
Mirvaso in Use Study
MIRVASO® In Use Study: Managing Rosacea Through Assessment and Control of Its Erythema (The MIRACLE Study)
Status: Enrolling
Updated: 11/21/2017
Manhattan Dermatology and Cosmetic Surgery
mi
from
New York, NY
Click here to add this to my saved trials
Mirvaso in Use Study
MIRVASO® In Use Study: Managing Rosacea Through Assessment and Control of Its Erythema (The MIRACLE Study)
Status: Enrolling
Updated:  11/21/2017
Arlington Research Center
mi
from
Arlington, TX
Mirvaso in Use Study
MIRVASO® In Use Study: Managing Rosacea Through Assessment and Control of Its Erythema (The MIRACLE Study)
Status: Enrolling
Updated: 11/21/2017
Arlington Research Center
mi
from
Arlington, TX
Click here to add this to my saved trials
Mirvaso in Use Study
MIRVASO® In Use Study: Managing Rosacea Through Assessment and Control of Its Erythema (The MIRACLE Study)
Status: Enrolling
Updated:  11/21/2017
Texas Dermatology and Laser Specialists
mi
from
San Antonio, TX
Mirvaso in Use Study
MIRVASO® In Use Study: Managing Rosacea Through Assessment and Control of Its Erythema (The MIRACLE Study)
Status: Enrolling
Updated: 11/21/2017
Texas Dermatology and Laser Specialists
mi
from
San Antonio, TX
Click here to add this to my saved trials
Mirvaso in Use Study
MIRVASO® In Use Study: Managing Rosacea Through Assessment and Control of Its Erythema (The MIRACLE Study)
Status: Enrolling
Updated:  11/21/2017
DermDox Centers for Dermatology
mi
from
Hazleton, PA
Mirvaso in Use Study
MIRVASO® In Use Study: Managing Rosacea Through Assessment and Control of Its Erythema (The MIRACLE Study)
Status: Enrolling
Updated: 11/21/2017
DermDox Centers for Dermatology
mi
from
Hazleton, PA
Click here to add this to my saved trials
Evaluation of the Ulthera® System for Treatment of the Face and Neck
Evaluation of the Ulthera® System for Obtaining Lift and Tightening of the Facial Tissue and Improvement in Jawline Definition and Submental Skin Laxity
Status: Enrolling
Updated:  11/22/2017
Dermatology, Cosmetic & Laser Surgery
mi
from
Rockville, MD
Evaluation of the Ulthera® System for Treatment of the Face and Neck
Evaluation of the Ulthera® System for Obtaining Lift and Tightening of the Facial Tissue and Improvement in Jawline Definition and Submental Skin Laxity
Status: Enrolling
Updated: 11/22/2017
Dermatology, Cosmetic & Laser Surgery
mi
from
Rockville, MD
Click here to add this to my saved trials
Monitoring of Tissue Transfer Flaps by Modulated Imaging
Non-contact, Intra-operative & Post-operative Device, Evaluation of Tissue Transfer Flaps After Reconstructive Surgery.
Status: Enrolling
Updated:  12/8/2017
University of California Medical Center
mi
from
Orange, CA
Monitoring of Tissue Transfer Flaps by Modulated Imaging
Non-contact, Intra-operative & Post-operative Device, Evaluation of Tissue Transfer Flaps After Reconstructive Surgery.
Status: Enrolling
Updated: 12/8/2017
University of California Medical Center
mi
from
Orange, CA
Click here to add this to my saved trials
The Role of Antibiotic Prophylaxis in Cleft Palate and Velopharyngeal Insufficiency Repair
The Role of Antibiotic Prophylaxis in Cleft Palate and Velopharyngeal Insufficiency Repair
Status: Enrolling
Updated:  12/19/2017
UF Health Shands Hospital
mi
from
Gainesville, FL
The Role of Antibiotic Prophylaxis in Cleft Palate and Velopharyngeal Insufficiency Repair
The Role of Antibiotic Prophylaxis in Cleft Palate and Velopharyngeal Insufficiency Repair
Status: Enrolling
Updated: 12/19/2017
UF Health Shands Hospital
mi
from
Gainesville, FL
Click here to add this to my saved trials
The Role of Antibiotic Prophylaxis in Cleft Palate and Velopharyngeal Insufficiency Repair
The Role of Antibiotic Prophylaxis in Cleft Palate and Velopharyngeal Insufficiency Repair
Status: Enrolling
Updated:  12/19/2017
University of Florida
mi
from
Gainesville, FL
The Role of Antibiotic Prophylaxis in Cleft Palate and Velopharyngeal Insufficiency Repair
The Role of Antibiotic Prophylaxis in Cleft Palate and Velopharyngeal Insufficiency Repair
Status: Enrolling
Updated: 12/19/2017
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Clinical Evaluation of Day and Night Skin Care Creams Supplemented With MediCell Technology (MCT)'s Composition of Defensins and Supportive Molecules
Clinical Evaluation of Day and Night Skin Care Creams Supplemented With MediCell Technology (MCT)'s Composition of Defensins and Supportive Molecules
Status: Enrolling
Updated:  1/9/2018
Advanced Dermatology
mi
from
Lincolnshire, IL
Clinical Evaluation of Day and Night Skin Care Creams Supplemented With MediCell Technology (MCT)'s Composition of Defensins and Supportive Molecules
Clinical Evaluation of Day and Night Skin Care Creams Supplemented With MediCell Technology (MCT)'s Composition of Defensins and Supportive Molecules
Status: Enrolling
Updated: 1/9/2018
Advanced Dermatology
mi
from
Lincolnshire, IL
Click here to add this to my saved trials
Oracea Soolantra Association in Patients With Severe Rosacea
Efficacy Comparison of Ivermectin 1% Topical Cream Associated With Doxycycline 40 mg Modified Release (MR) Capsules Versus Ivermectin 1% Topical Cream Associated With Placebo in the Treatment of Severe Rosacea
Status: Enrolling
Updated:  1/11/2018
Private Practice
mi
from
Fort Smith, AR
Oracea Soolantra Association in Patients With Severe Rosacea
Efficacy Comparison of Ivermectin 1% Topical Cream Associated With Doxycycline 40 mg Modified Release (MR) Capsules Versus Ivermectin 1% Topical Cream Associated With Placebo in the Treatment of Severe Rosacea
Status: Enrolling
Updated: 1/11/2018
Private Practice
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Oracea Soolantra Association in Patients With Severe Rosacea
Efficacy Comparison of Ivermectin 1% Topical Cream Associated With Doxycycline 40 mg Modified Release (MR) Capsules Versus Ivermectin 1% Topical Cream Associated With Placebo in the Treatment of Severe Rosacea
Status: Enrolling
Updated:  1/11/2018
Private practice
mi
from
Sacramento, CA
Oracea Soolantra Association in Patients With Severe Rosacea
Efficacy Comparison of Ivermectin 1% Topical Cream Associated With Doxycycline 40 mg Modified Release (MR) Capsules Versus Ivermectin 1% Topical Cream Associated With Placebo in the Treatment of Severe Rosacea
Status: Enrolling
Updated: 1/11/2018
Private practice
mi
from
Sacramento, CA
Click here to add this to my saved trials
Oracea Soolantra Association in Patients With Severe Rosacea
Efficacy Comparison of Ivermectin 1% Topical Cream Associated With Doxycycline 40 mg Modified Release (MR) Capsules Versus Ivermectin 1% Topical Cream Associated With Placebo in the Treatment of Severe Rosacea
Status: Enrolling
Updated:  1/11/2018
Private practice
mi
from
Boca Raton, FL
Oracea Soolantra Association in Patients With Severe Rosacea
Efficacy Comparison of Ivermectin 1% Topical Cream Associated With Doxycycline 40 mg Modified Release (MR) Capsules Versus Ivermectin 1% Topical Cream Associated With Placebo in the Treatment of Severe Rosacea
Status: Enrolling
Updated: 1/11/2018
Private practice
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Oracea Soolantra Association in Patients With Severe Rosacea
Efficacy Comparison of Ivermectin 1% Topical Cream Associated With Doxycycline 40 mg Modified Release (MR) Capsules Versus Ivermectin 1% Topical Cream Associated With Placebo in the Treatment of Severe Rosacea
Status: Enrolling
Updated:  1/11/2018
Private practice
mi
from
Louisville, KY
Oracea Soolantra Association in Patients With Severe Rosacea
Efficacy Comparison of Ivermectin 1% Topical Cream Associated With Doxycycline 40 mg Modified Release (MR) Capsules Versus Ivermectin 1% Topical Cream Associated With Placebo in the Treatment of Severe Rosacea
Status: Enrolling
Updated: 1/11/2018
Private practice
mi
from
Louisville, KY
Click here to add this to my saved trials
Oracea Soolantra Association in Patients With Severe Rosacea
Efficacy Comparison of Ivermectin 1% Topical Cream Associated With Doxycycline 40 mg Modified Release (MR) Capsules Versus Ivermectin 1% Topical Cream Associated With Placebo in the Treatment of Severe Rosacea
Status: Enrolling
Updated:  1/11/2018
Private Practice
mi
from
Metairie, LA
Oracea Soolantra Association in Patients With Severe Rosacea
Efficacy Comparison of Ivermectin 1% Topical Cream Associated With Doxycycline 40 mg Modified Release (MR) Capsules Versus Ivermectin 1% Topical Cream Associated With Placebo in the Treatment of Severe Rosacea
Status: Enrolling
Updated: 1/11/2018
Private Practice
mi
from
Metairie, LA
Click here to add this to my saved trials
Oracea Soolantra Association in Patients With Severe Rosacea
Efficacy Comparison of Ivermectin 1% Topical Cream Associated With Doxycycline 40 mg Modified Release (MR) Capsules Versus Ivermectin 1% Topical Cream Associated With Placebo in the Treatment of Severe Rosacea
Status: Enrolling
Updated:  1/11/2018
Private practice
mi
from
Omaha, NE
Oracea Soolantra Association in Patients With Severe Rosacea
Efficacy Comparison of Ivermectin 1% Topical Cream Associated With Doxycycline 40 mg Modified Release (MR) Capsules Versus Ivermectin 1% Topical Cream Associated With Placebo in the Treatment of Severe Rosacea
Status: Enrolling
Updated: 1/11/2018
Private practice
mi
from
Omaha, NE
Click here to add this to my saved trials
Oracea Soolantra Association in Patients With Severe Rosacea
Efficacy Comparison of Ivermectin 1% Topical Cream Associated With Doxycycline 40 mg Modified Release (MR) Capsules Versus Ivermectin 1% Topical Cream Associated With Placebo in the Treatment of Severe Rosacea
Status: Enrolling
Updated:  1/11/2018
Private practice
mi
from
Las Vegas, NV
Oracea Soolantra Association in Patients With Severe Rosacea
Efficacy Comparison of Ivermectin 1% Topical Cream Associated With Doxycycline 40 mg Modified Release (MR) Capsules Versus Ivermectin 1% Topical Cream Associated With Placebo in the Treatment of Severe Rosacea
Status: Enrolling
Updated: 1/11/2018
Private practice
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oracea Soolantra Association in Patients With Severe Rosacea
Efficacy Comparison of Ivermectin 1% Topical Cream Associated With Doxycycline 40 mg Modified Release (MR) Capsules Versus Ivermectin 1% Topical Cream Associated With Placebo in the Treatment of Severe Rosacea
Status: Enrolling
Updated:  1/11/2018
Private practice
mi
from
Pflugerville, TX
Oracea Soolantra Association in Patients With Severe Rosacea
Efficacy Comparison of Ivermectin 1% Topical Cream Associated With Doxycycline 40 mg Modified Release (MR) Capsules Versus Ivermectin 1% Topical Cream Associated With Placebo in the Treatment of Severe Rosacea
Status: Enrolling
Updated: 1/11/2018
Private practice
mi
from
Pflugerville, TX
Click here to add this to my saved trials
Oracea Soolantra Association in Patients With Severe Rosacea
Efficacy Comparison of Ivermectin 1% Topical Cream Associated With Doxycycline 40 mg Modified Release (MR) Capsules Versus Ivermectin 1% Topical Cream Associated With Placebo in the Treatment of Severe Rosacea
Status: Enrolling
Updated:  1/11/2018
Private practice
mi
from
Markham,
Oracea Soolantra Association in Patients With Severe Rosacea
Efficacy Comparison of Ivermectin 1% Topical Cream Associated With Doxycycline 40 mg Modified Release (MR) Capsules Versus Ivermectin 1% Topical Cream Associated With Placebo in the Treatment of Severe Rosacea
Status: Enrolling
Updated: 1/11/2018
Private practice
mi
from
Markham,
Click here to add this to my saved trials
The Effect of Dermatology and Teledermatology Consultations on Length of Hospital Admission, 30 Day Readmission Rate, and Antibiotic Use in Patients Presenting With Cellulitis vs Pseudocellulitis in an Academic Inpatient Setting
The Effect of Dermatology and Teledermatology Consultations on Length of Hospital Admission, 30 Day Readmission Rate, and Antibiotic Use in Patients Presenting With Cellulitis vs Pseudocellulitis in an Academic Inpatient Setting
Status: Enrolling
Updated:  1/16/2018
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
The Effect of Dermatology and Teledermatology Consultations on Length of Hospital Admission, 30 Day Readmission Rate, and Antibiotic Use in Patients Presenting With Cellulitis vs Pseudocellulitis in an Academic Inpatient Setting
The Effect of Dermatology and Teledermatology Consultations on Length of Hospital Admission, 30 Day Readmission Rate, and Antibiotic Use in Patients Presenting With Cellulitis vs Pseudocellulitis in an Academic Inpatient Setting
Status: Enrolling
Updated: 1/16/2018
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Study of a Novel Microlens Array Device for Skin Rejuvenation
A Single-Center, Open-Label Pilot Study of a Novel Microlens Array Device for Skin Rejuvenation
Status: Enrolling
Updated:  1/18/2018
Cutera Research Center
mi
from
Brisbane, CA
Study of a Novel Microlens Array Device for Skin Rejuvenation
A Single-Center, Open-Label Pilot Study of a Novel Microlens Array Device for Skin Rejuvenation
Status: Enrolling
Updated: 1/18/2018
Cutera Research Center
mi
from
Brisbane, CA
Click here to add this to my saved trials
Efficacy of Natural Vitamin E Tocotrienol on the Treatment of Surgical Scars
Efficacy of Natural Vitamin E Tocotrienol on the Treatment of Surgical Scars
Status: Enrolling
Updated:  1/25/2018
OSU Plastic Surgery - Knightsbridge
mi
from
Columbus, OH
Efficacy of Natural Vitamin E Tocotrienol on the Treatment of Surgical Scars
Efficacy of Natural Vitamin E Tocotrienol on the Treatment of Surgical Scars
Status: Enrolling
Updated: 1/25/2018
OSU Plastic Surgery - Knightsbridge
mi
from
Columbus, OH
Click here to add this to my saved trials
Efficacy of Natural Vitamin E Tocotrienol on the Treatment of Surgical Scars
Efficacy of Natural Vitamin E Tocotrienol on the Treatment of Surgical Scars
Status: Enrolling
Updated:  1/25/2018
Ohio State University
mi
from
Columbus, OH
Efficacy of Natural Vitamin E Tocotrienol on the Treatment of Surgical Scars
Efficacy of Natural Vitamin E Tocotrienol on the Treatment of Surgical Scars
Status: Enrolling
Updated: 1/25/2018
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Efficacy Of Tocotrienol a Natural Vitamin E In Biopsy Wound
Efficacy Of Tocotrienol a Natural Vitamin E In Biopsy Wound.
Status: Enrolling
Updated:  1/25/2018
Ohio State University Medical Center
mi
from
Columbus, OH
Efficacy Of Tocotrienol a Natural Vitamin E In Biopsy Wound
Efficacy Of Tocotrienol a Natural Vitamin E In Biopsy Wound.
Status: Enrolling
Updated: 1/25/2018
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Feasibility Study: Evaluation of the Treatment of Striae Using Ultherapy® in Combination With Laser Treatment
Feasibility Study: Evaluation of the Ulthera® System in Combination With 70W Alma Pixel CO2 Fractional Ablative Laser for Improvement of Abdominal Striae
Status: Enrolling
Updated:  1/30/2018
Art Plastic Surgery
mi
from
Paramus, NJ
Feasibility Study: Evaluation of the Treatment of Striae Using Ultherapy® in Combination With Laser Treatment
Feasibility Study: Evaluation of the Ulthera® System in Combination With 70W Alma Pixel CO2 Fractional Ablative Laser for Improvement of Abdominal Striae
Status: Enrolling
Updated: 1/30/2018
Art Plastic Surgery
mi
from
Paramus, NJ
Click here to add this to my saved trials
Feasibility Study: Evaluation of the Treatment of Striae Using Ultherapy® in Combination With Laser Treatment
Feasibility Study: Evaluation of the Ulthera® System in Combination With 70W Alma Pixel CO2 Fractional Ablative Laser for Improvement of Abdominal Striae
Status: Enrolling
Updated:  1/30/2018
Dermatology, Laser & Vein Specialists of the Carolinas PLLC
mi
from
Charlotte, NC
Feasibility Study: Evaluation of the Treatment of Striae Using Ultherapy® in Combination With Laser Treatment
Feasibility Study: Evaluation of the Ulthera® System in Combination With 70W Alma Pixel CO2 Fractional Ablative Laser for Improvement of Abdominal Striae
Status: Enrolling
Updated: 1/30/2018
Dermatology, Laser & Vein Specialists of the Carolinas PLLC
mi
from
Charlotte, NC
Click here to add this to my saved trials
Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea
Evaluation of the Safety and Efficacy of the Ulthera® System for the Treatment of Signs and Symptoms of Erythematotelangiectatic Rosacea
Status: Enrolling
Updated:  1/30/2018
Skin Specialists, PC
mi
from
Omaha, NE
Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea
Evaluation of the Safety and Efficacy of the Ulthera® System for the Treatment of Signs and Symptoms of Erythematotelangiectatic Rosacea
Status: Enrolling
Updated: 1/30/2018
Skin Specialists, PC
mi
from
Omaha, NE
Click here to add this to my saved trials
Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea
Evaluation of the Safety and Efficacy of the Ulthera® System for the Treatment of Signs and Symptoms of Erythematotelangiectatic Rosacea
Status: Enrolling
Updated:  1/30/2018
Wilmington Dermatology Center
mi
from
Wilmington, NC
Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea
Evaluation of the Safety and Efficacy of the Ulthera® System for the Treatment of Signs and Symptoms of Erythematotelangiectatic Rosacea
Status: Enrolling
Updated: 1/30/2018
Wilmington Dermatology Center
mi
from
Wilmington, NC
Click here to add this to my saved trials
Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea
Evaluation of the Safety and Efficacy of the Ulthera® System for the Treatment of Signs and Symptoms of Erythematotelangiectatic Rosacea
Status: Enrolling
Updated:  1/30/2018
All About Faces
mi
from
Hummelstown, PA
Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea
Evaluation of the Safety and Efficacy of the Ulthera® System for the Treatment of Signs and Symptoms of Erythematotelangiectatic Rosacea
Status: Enrolling
Updated: 1/30/2018
All About Faces
mi
from
Hummelstown, PA
Click here to add this to my saved trials
Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea
Evaluation of the Safety and Efficacy of the Ulthera® System for the Treatment of Signs and Symptoms of Erythematotelangiectatic Rosacea
Status: Enrolling
Updated:  1/30/2018
Laser & Cosmetic Center
mi
from
Virginia Beach, VA
Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea
Evaluation of the Safety and Efficacy of the Ulthera® System for the Treatment of Signs and Symptoms of Erythematotelangiectatic Rosacea
Status: Enrolling
Updated: 1/30/2018
Laser & Cosmetic Center
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea
Evaluation of the Safety and Efficacy of the Ulthera® System for the Treatment of Signs and Symptoms of Erythematotelangiectatic Rosacea
Status: Enrolling
Updated:  1/30/2018
Cosmedica Laser Centre
mi
from
Victoria,
Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea
Evaluation of the Safety and Efficacy of the Ulthera® System for the Treatment of Signs and Symptoms of Erythematotelangiectatic Rosacea
Status: Enrolling
Updated: 1/30/2018
Cosmedica Laser Centre
mi
from
Victoria,
Click here to add this to my saved trials
MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.
Efficacy and Safety of Ivermectin 1% Topical Cream Associated With Brimonidine 0.33% Topical Gel in the Treatment of Moderate to Severe Rosacea
Status: Enrolling
Updated:  2/13/2018
Clinical Research Facility
mi
from
Fort Smith, AR
MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.
Efficacy and Safety of Ivermectin 1% Topical Cream Associated With Brimonidine 0.33% Topical Gel in the Treatment of Moderate to Severe Rosacea
Status: Enrolling
Updated: 2/13/2018
Clinical Research Facility
mi
from
Fort Smith, AR
Click here to add this to my saved trials
MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.
Efficacy and Safety of Ivermectin 1% Topical Cream Associated With Brimonidine 0.33% Topical Gel in the Treatment of Moderate to Severe Rosacea
Status: Enrolling
Updated:  2/13/2018
Clinical Research Facility
mi
from
Rogers, AR
MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.
Efficacy and Safety of Ivermectin 1% Topical Cream Associated With Brimonidine 0.33% Topical Gel in the Treatment of Moderate to Severe Rosacea
Status: Enrolling
Updated: 2/13/2018
Clinical Research Facility
mi
from
Rogers, AR
Click here to add this to my saved trials
MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.
Efficacy and Safety of Ivermectin 1% Topical Cream Associated With Brimonidine 0.33% Topical Gel in the Treatment of Moderate to Severe Rosacea
Status: Enrolling
Updated:  2/13/2018
Clinical Research Facility
mi
from
Sacramento, CA
MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.
Efficacy and Safety of Ivermectin 1% Topical Cream Associated With Brimonidine 0.33% Topical Gel in the Treatment of Moderate to Severe Rosacea
Status: Enrolling
Updated: 2/13/2018
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.
Efficacy and Safety of Ivermectin 1% Topical Cream Associated With Brimonidine 0.33% Topical Gel in the Treatment of Moderate to Severe Rosacea
Status: Enrolling
Updated:  2/13/2018
Clinical Research Facility
mi
from
Orlando, FL
MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.
Efficacy and Safety of Ivermectin 1% Topical Cream Associated With Brimonidine 0.33% Topical Gel in the Treatment of Moderate to Severe Rosacea
Status: Enrolling
Updated: 2/13/2018
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.
Efficacy and Safety of Ivermectin 1% Topical Cream Associated With Brimonidine 0.33% Topical Gel in the Treatment of Moderate to Severe Rosacea
Status: Enrolling
Updated:  2/13/2018
Clinical Research Facility
mi
from
Omaha, NE
MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.
Efficacy and Safety of Ivermectin 1% Topical Cream Associated With Brimonidine 0.33% Topical Gel in the Treatment of Moderate to Severe Rosacea
Status: Enrolling
Updated: 2/13/2018
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.
Efficacy and Safety of Ivermectin 1% Topical Cream Associated With Brimonidine 0.33% Topical Gel in the Treatment of Moderate to Severe Rosacea
Status: Enrolling
Updated:  2/13/2018
Clinical Research Facility
mi
from
New York, NY
MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.
Efficacy and Safety of Ivermectin 1% Topical Cream Associated With Brimonidine 0.33% Topical Gel in the Treatment of Moderate to Severe Rosacea
Status: Enrolling
Updated: 2/13/2018
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.
Efficacy and Safety of Ivermectin 1% Topical Cream Associated With Brimonidine 0.33% Topical Gel in the Treatment of Moderate to Severe Rosacea
Status: Enrolling
Updated:  2/13/2018
Clinical Research Facility
mi
from
Pflugerville, TX
MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.
Efficacy and Safety of Ivermectin 1% Topical Cream Associated With Brimonidine 0.33% Topical Gel in the Treatment of Moderate to Severe Rosacea
Status: Enrolling
Updated: 2/13/2018
Clinical Research Facility
mi
from
Pflugerville, TX
Click here to add this to my saved trials
MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.
Efficacy and Safety of Ivermectin 1% Topical Cream Associated With Brimonidine 0.33% Topical Gel in the Treatment of Moderate to Severe Rosacea
Status: Enrolling
Updated:  2/13/2018
Research Site
mi
from
Surrey,
MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.
Efficacy and Safety of Ivermectin 1% Topical Cream Associated With Brimonidine 0.33% Topical Gel in the Treatment of Moderate to Severe Rosacea
Status: Enrolling
Updated: 2/13/2018
Research Site
mi
from
Surrey,
Click here to add this to my saved trials
Cohort 2 Efficacy of Nasopharyngeal Ventilation With Endotracheal Tube for Surgery
Cohort 2 Efficacy of Nasopharyngeal Ventilation With Endotracheal Tube for Patients With Predicted Difficult to Mask Ventilate
Status: Enrolling
Updated:  2/14/2018
University of Louisville
mi
from
Louisville, KY
Cohort 2 Efficacy of Nasopharyngeal Ventilation With Endotracheal Tube for Surgery
Cohort 2 Efficacy of Nasopharyngeal Ventilation With Endotracheal Tube for Patients With Predicted Difficult to Mask Ventilate
Status: Enrolling
Updated: 2/14/2018
University of Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle
A Phase 3, Randomized, Vehicle-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Once-Daily CLS001 Topical Gel Versus Vehicle Administered for 12 Weeks to Subjects With Papulopustular Rosacea With a 4 Week Follow-up Period
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Rogers, AR
Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle
A Phase 3, Randomized, Vehicle-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Once-Daily CLS001 Topical Gel Versus Vehicle Administered for 12 Weeks to Subjects With Papulopustular Rosacea With a 4 Week Follow-up Period
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Rogers, AR
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle
A Phase 3, Randomized, Vehicle-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Once-Daily CLS001 Topical Gel Versus Vehicle Administered for 12 Weeks to Subjects With Papulopustular Rosacea With a 4 Week Follow-up Period
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Oceanside, CA
Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle
A Phase 3, Randomized, Vehicle-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Once-Daily CLS001 Topical Gel Versus Vehicle Administered for 12 Weeks to Subjects With Papulopustular Rosacea With a 4 Week Follow-up Period
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Oceanside, CA
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle
A Phase 3, Randomized, Vehicle-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Once-Daily CLS001 Topical Gel Versus Vehicle Administered for 12 Weeks to Subjects With Papulopustular Rosacea With a 4 Week Follow-up Period
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Boynton Beach, FL
Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle
A Phase 3, Randomized, Vehicle-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Once-Daily CLS001 Topical Gel Versus Vehicle Administered for 12 Weeks to Subjects With Papulopustular Rosacea With a 4 Week Follow-up Period
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle
A Phase 3, Randomized, Vehicle-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Once-Daily CLS001 Topical Gel Versus Vehicle Administered for 12 Weeks to Subjects With Papulopustular Rosacea With a 4 Week Follow-up Period
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Plainfield, IN
Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle
A Phase 3, Randomized, Vehicle-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Once-Daily CLS001 Topical Gel Versus Vehicle Administered for 12 Weeks to Subjects With Papulopustular Rosacea With a 4 Week Follow-up Period
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Plainfield, IN
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle
A Phase 3, Randomized, Vehicle-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Once-Daily CLS001 Topical Gel Versus Vehicle Administered for 12 Weeks to Subjects With Papulopustular Rosacea With a 4 Week Follow-up Period
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Watertown, MA
Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle
A Phase 3, Randomized, Vehicle-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Once-Daily CLS001 Topical Gel Versus Vehicle Administered for 12 Weeks to Subjects With Papulopustular Rosacea With a 4 Week Follow-up Period
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Watertown, MA
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle
A Phase 3, Randomized, Vehicle-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Once-Daily CLS001 Topical Gel Versus Vehicle Administered for 12 Weeks to Subjects With Papulopustular Rosacea With a 4 Week Follow-up Period
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Omaha, NE
Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle
A Phase 3, Randomized, Vehicle-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Once-Daily CLS001 Topical Gel Versus Vehicle Administered for 12 Weeks to Subjects With Papulopustular Rosacea With a 4 Week Follow-up Period
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle
A Phase 3, Randomized, Vehicle-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Once-Daily CLS001 Topical Gel Versus Vehicle Administered for 12 Weeks to Subjects With Papulopustular Rosacea With a 4 Week Follow-up Period
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Verona, NJ
Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle
A Phase 3, Randomized, Vehicle-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Once-Daily CLS001 Topical Gel Versus Vehicle Administered for 12 Weeks to Subjects With Papulopustular Rosacea With a 4 Week Follow-up Period
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Verona, NJ
Click here to add this to my saved trials